Atelerix Life Sciences

Available Data

[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text]

In-vitro and animal data show pre-clinical proof of concept.

[/vc_column_text][vc_empty_space][/vc_column][/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column width=”1/2″][vc_column_text]

Click Here For Pre-Clinical Proof of Concept

[/vc_column_text][vc_column_text]ATLX-0190 is active on ventilatory control systems.

– Elicits substantial increases in minute ventilation, diaphragmatic-EMG (DIA-EMG), genioglossus-EMG (GG-EMG) with minor changes in mean arterial blood pressure (MABP) in freely moving and in isoflurane-anesthetized naïve rats

ATLX-0190 reverses the ventilatory-depressant effects of morphine in freely-moving rats.

– Elicits a sustained reversal of morphine-induced decrease in Minute Ventilation

– Elicits a sustained reversal of morphine-induced decrease in Peak Inspiratory Flow

– Elicits a sustained reversal of morphine-induced decrease in Inspiratory Drive

ATLX-0190 reverses the negative effects of morphine on arterial blood-gas chemistry in freely-moving rats.

Reverses morphine-induced decreases in blood pH

– Modulates morphine-induced changes in pCO2, pO2, sO2, and the A-a gradient

Reverses morphine-induced decreases in blood pH

– Modulates morphine-induced changes in pCO2, pO2, sO2, and the A-a gradient[/vc_column_text][/vc_column][vc_column width=”1/2″][vc_column_text]

Click Here For Appendices

[/vc_column_text][vc_column_text]ATLX-0190 does not effect opioid-induced analgesia in freely-moving rats.

ATLX-0190 diminishes withdrawal responses in morphine-dependent rats.

ATLX-0190 may modulate addiction.

Co-infusion of ATLX-0190 with morphine reduces NLX-precipitated withdrawal in morphine-dependent rats.

Acute co-administration of ATLX-0190 with NLX reduces NLX-precipitated withdrawal in morphine-dependent rats.

[/vc_column_text][/vc_column][/vc_row]